Found: 11
Select item for more details and to access through your institution.
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 947, doi. 10.1002/cac2.12448
- By:
- Publication type:
- Article
Cover Image, Volume 43, Issue 6.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. i, doi. 10.1002/cac2.12477
- By:
- Publication type:
- Article
The MonarchE trial: improving the clinical outcome in HR<sup>+</sup>/HER2<sup>−</sup> early breast cancer: recent results and next steps.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 938, doi. 10.1002/cac2.12466
- By:
- Publication type:
- Article
Lung cancer risk score for ever and never smokers in China.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 877, doi. 10.1002/cac2.12463
- By:
- Publication type:
- Article
Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 896, doi. 10.1002/cac2.12462
- By:
- Publication type:
- Article
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 909, doi. 10.1002/cac2.12459
- By:
- Publication type:
- Article
Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 863, doi. 10.1002/cac2.12454
- By:
- Publication type:
- Article
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 956, doi. 10.1002/cac2.12450
- By:
- Publication type:
- Article
Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 951, doi. 10.1002/cac2.12449
- By:
- Publication type:
- Article
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 943, doi. 10.1002/cac2.12447
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 861, doi. 10.1002/cac2.12305
- Publication type:
- Article